BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 23913683)

  • 1. A novel function of CRL4(Cdt2): regulation of the subunit structure of DNA polymerase δ in response to DNA damage and during the S phase.
    Zhang S; Zhao H; Darzynkiewicz Z; Zhou P; Zhang Z; Lee EY; Lee MY
    J Biol Chem; 2013 Oct; 288(41):29550-61. PubMed ID: 23913683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tail that wags the dog: p12, the smallest subunit of DNA polymerase δ, is degraded by ubiquitin ligases in response to DNA damage and during cell cycle progression.
    Lee MY; Zhang S; Lin SH; Wang X; Darzynkiewicz Z; Zhang Z; Lee EY
    Cell Cycle; 2014; 13(1):23-31. PubMed ID: 24300032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the p12 subunit of human DNA polymerase δ (Pol δ), CDK inhibitor p21(WAF1), Cdt1, cyclin A, PCNA and Ki-67 in relation to DNA replication in individual cells.
    Zhao H; Zhang S; Xu D; Lee MY; Zhang Z; Lee EY; Darzynkiewicz Z
    Cell Cycle; 2014; 13(22):3529-40. PubMed ID: 25483089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of p12 subunit by CRL4Cdt2 E3 ligase inhibits fork progression after DNA damage.
    Terai K; Shibata E; Abbas T; Dutta A
    J Biol Chem; 2013 Oct; 288(42):30509-30514. PubMed ID: 24022480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferating cell nuclear antigen interacts with the CRL4 ubiquitin ligase subunit CDT2 in DNA synthesis-induced degradation of CDT1.
    Leng F; Saxena L; Hoang N; Zhang C; Lee L; Li W; Gong X; Lu F; Sun H; Zhang H
    J Biol Chem; 2018 Dec; 293(49):18879-18889. PubMed ID: 30301766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRL4Cdt2 E3 ubiquitin ligase and proliferating cell nuclear antigen (PCNA) cooperate to degrade thymine DNA glycosylase in S phase.
    Shibata E; Dar A; Dutta A
    J Biol Chem; 2014 Aug; 289(33):23056-23064. PubMed ID: 24962565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatiotemporal recruitment of human DNA polymerase delta to sites of UV damage.
    Chea J; Zhang S; Zhao H; Zhang Z; Lee EY; Darzynkiewicz Z; Lee MY
    Cell Cycle; 2012 Aug; 11(15):2885-95. PubMed ID: 22801543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of the p12 subunit of DNA polymerase delta leads to a defect in HR and sensitization to PARP inhibitors.
    Zhang S; Chao HH; Wang X; Zhang Z; Lee EYC; Lee MYWT
    DNA Repair (Amst); 2019 Jan; 73():64-70. PubMed ID: 30470508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel DNA damage response: rapid degradation of the p12 subunit of dna polymerase delta.
    Zhang S; Zhou Y; Trusa S; Meng X; Lee EY; Lee MY
    J Biol Chem; 2007 May; 282(21):15330-40. PubMed ID: 17317665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective ubiquitylation of p21 and Cdt1 by UBCH8 and UBE2G ubiquitin-conjugating enzymes via the CRL4Cdt2 ubiquitin ligase complex.
    Shibata E; Abbas T; Huang X; Wohlschlegel JA; Dutta A
    Mol Cell Biol; 2011 Aug; 31(15):3136-45. PubMed ID: 21628527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of the CRL4-CDT2-SET8/p21 ubiquitylation and degradation axis underlies the therapeutic efficacy of pevonedistat in melanoma.
    Benamar M; Guessous F; Du K; Corbett P; Obeid J; Gioeli D; Slingluff CL; Abbas T
    EBioMedicine; 2016 Aug; 10():85-100. PubMed ID: 27333051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDK1-dependent inhibition of the E3 ubiquitin ligase CRL4CDT2 ensures robust transition from S Phase to Mitosis.
    Rizzardi LF; Coleman KE; Varma D; Matson JP; Oh S; Cook JG
    J Biol Chem; 2015 Jan; 290(1):556-67. PubMed ID: 25411249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRL4(Cdt2)-mediated destruction of the histone methyltransferase Set8 prevents premature chromatin compaction in S phase.
    Centore RC; Havens CG; Manning AL; Li JM; Flynn RL; Tse A; Jin J; Dyson NJ; Walter JC; Zou L
    Mol Cell; 2010 Oct; 40(1):22-33. PubMed ID: 20932472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C/EBPα regulates CRL4(Cdt2)-mediated degradation of p21 in response to UVB-induced DNA damage to control the G1/S checkpoint.
    Hall JR; Bereman MS; Nepomuceno AI; Thompson EA; Muddiman DC; Smart RC
    Cell Cycle; 2014; 13(22):3602-10. PubMed ID: 25483090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Checkpoint kinase ATR phosphorylates Cdt2, a substrate receptor of CRL4 ubiquitin ligase, and promotes the degradation of Cdt1 following UV irradiation.
    Sakaguchi H; Takami T; Yasutani Y; Maeda T; Morino M; Ishii T; Shiomi Y; Nishitani H
    PLoS One; 2012; 7(9):e46480. PubMed ID: 23029527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two forms of human DNA polymerase δ: Who does what and why?
    Lee MYWT; Zhang S; Wang X; Chao HH; Zhao H; Darzynkiewicz Z; Zhang Z; Lee EYC
    DNA Repair (Amst); 2019 Sep; 81():102656. PubMed ID: 31326365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIP degron proteins, substrates of CRL4Cdt2, and not PIP boxes, interfere with DNA polymerase η and κ focus formation on UV damage.
    Tsanov N; Kermi C; Coulombe P; Van der Laan S; Hodroj D; Maiorano D
    Nucleic Acids Res; 2014 Apr; 42(6):3692-706. PubMed ID: 24423875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRL4(CDT2) targets CHK1 for PCNA-independent destruction.
    Huh J; Piwnica-Worms H
    Mol Cell Biol; 2013 Jan; 33(2):213-26. PubMed ID: 23109433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin E3 ligase CRL4(CDT2/DCAF2) as a potential chemotherapeutic target for ovarian surface epithelial cancer.
    Pan WW; Zhou JJ; Yu C; Xu Y; Guo LJ; Zhang HY; Zhou D; Song FZ; Fan HY
    J Biol Chem; 2013 Oct; 288(41):29680-91. PubMed ID: 23995842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docking of a specialized PIP Box onto chromatin-bound PCNA creates a degron for the ubiquitin ligase CRL4Cdt2.
    Havens CG; Walter JC
    Mol Cell; 2009 Jul; 35(1):93-104. PubMed ID: 19595719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.